NPPA fixes retail price of 68 drug formulations
Drug price regulator NPPA Friday fixed prices as well as revised ceiling and retail prices of 68 formulations, including those used for treatment of diabetes, blood pressure and HIV. The…
Teva Pharm raises 2018 Profit outlook, sees strong migraine drug launch
By Tova Cohen and Steven Scheer TEL AVIV: Teva Pharmaceutical Industries raised its 2018 earnings outlook, said it was seeing “a very strong launch” for its long-awaited migraine treatment Ajovy…
Takeda hikes annual profit forecast by a third after second-quarter profit jump
By Takashi Umekawa TOKYO: Japan’s Takeda Pharmaceutical Co Ltd on Wednesday boosted its annual operating profit outlook by a third after second-quarter earnings surged on strong global sales of its…
Amgen posts higher quarterly EPS, Repatha sales fall short
By Deena Beasley Amgen Inc on Tuesday said stock buybacks lifted its third-quarter earnings per share, but operating income fell as expenses rose and sales of some key products declined.…
Private equity firm EQT launches $654 mln cash bid for Sweden’s Karo Pharma
STOCKHOLM: Private equity firm EQT on Monday made a recommended 5.97 billion Swedish crown ($654 million) cash bid to buy Swedish specialty pharma group Karo Pharma. The offer, made by…
Glenmark gets USFDA nod for generic skin inflammation oil
New Delhi: Glenmark Pharmaceuticals Friday said its US arm has received final nod from the US health regulator for generic Fluocinolone Acetonide Topical oil used for treatment of inflammation of…
Gilead hepatitis C drug sales fall, but profit beats estimates
By Deena Beasley Second quarter sales of Gilead Sciences Inc’s flagship hepatitis C drugs fell by more than half as competition increased, sending net profit down 22 percent from a…
US approves first new type of flu drug in 2 decades
TRENTON, N.J: U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday’s approval of Xofluza for people age 12 and older comes ahead of…
Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain
By Manojna Maddipatla and Tamara Mathias A non-opioid drug developed by Pfizer and Eli Lilly met the main goals of a late-stage study, in which over half of the patients…
Sun Pharma launches psoriasis treatment drug Ilumya in US
Sun Pharmaceutical Industries Tuesday said it has launched its plaque psoriasis treatment drug Ilumya (tildrakizumab-asmn) in the US market.Ilumya in the strength of 100 mg/mL is now available in the…